The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

▶ CNBC Top News Aug 6, 2026 17h ago 👁 4 views

📋 Article Summary

50 words

As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline. As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.

ⓘ Summary only. Read the complete story on CNBC Top News below.

Full story on CNBC Top News

Read Full Article →

🔗 You will be taken to www.cnbc.com

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.